|
Volumn 22, Issue 3, 2013, Pages 162-167
|
One goal, different strategies - molecular and cellular approaches for the treatment of inherited skin fragility disorders
|
Author keywords
Blistering disease; Epidermolysis bullosa; Fibroblast and protein therapy; Gene therapy; Mesenchymal stromal cell; Stem cell transplantation
|
Indexed keywords
5' NUCLEOTIDASE;
COLLAGEN TYPE 7;
CYTOKERATIN 14;
CYTOKERATIN 5;
ENDOGLIN;
HLA DR ANTIGEN;
KALININ;
LAMININ;
LAMININ BETA 3;
MESSENGER RNA;
SMALL INTERFERING RNA;
THY 1 ANTIGEN;
UNCLASSIFIED DRUG;
BONE MARROW TRANSPLANTATION;
EPIDERMOLYSIS BULLOSA;
FIBROBLAST;
GENE SILENCING;
GENE THERAPY;
GRAFT VERSUS HOST REACTION;
HEMATOPOIETIC STEM CELL;
HUMAN;
KERATINOCYTE;
MESENCHYMAL STEM CELL TRANSPLANTATION;
PLURIPOTENT STEM CELL;
POINT MUTATION;
PROTEIN EXPRESSION;
REVIEW;
SKIN FRAGILITY;
CELL- AND TISSUE-BASED THERAPY;
DISEASE MANAGEMENT;
EPIDERMOLYSIS BULLOSA;
GENE SILENCING;
GENETIC THERAPY;
GOALS;
HUMANS;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
|
EID: 84875016051
PISSN: 09066705
EISSN: 16000625
Source Type: Journal
DOI: 10.1111/exd.12084 Document Type: Review |
Times cited : (16)
|
References (65)
|